Consolidated And Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
Filed with BSE · · 13 pages · English
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Nov 04 2025
- Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.
- Titan Biotech Limited Press Release Oct 09 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Titan Biotech Limited Press Release Sep 29 2025
Later from Titan Biotech
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Nov 12 2025
- Closure of Trading Window
- Board Meeting Intimation for Proposal For Alteration In The Share Capital Of The Company By Sub-Division / Split Of Existing Equity Shares
- Titan Biotech Limited Press Release Nov 25 2025
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech